U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Quotables

"Telephone, n. An invention of the devil which abrogates some of the advantages of making a disagreeable person keep his distance. "

Ambose Bierce

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Attorney: Kelly; Patrick D.


Number of patents: 71
Last date: September 13, 2011

1    
NumberTitleIssue Date
8018079Reciprocating system with buoyant aircraft, spinnaker sail, and heavy cars for generating electric power
An electric generating system uses a zeppelin filled with helium or hydrogen, and a spinnaker sail, to provide pulling power that will lift a heavy railcar to an elevated height on a track, such as on a hill or mountainside, or in an elevator-type shaft in a tall bu...
09/13/2011
7973296Electromagnetic systems with double-resonant spiral coil components
Spiral coils generate very powerful electromagnetic fields by operating with two different but simultaneous resonant behaviors. Quarter-wave resonance is established by adjusting the frequency (and wavelength) of a radiofrequency (RF) voltage source until the length...
07/05/2011
7476250Semi-permeable membranes to assist in cartilage repair
A semi-permeable membrane can be used to promote the surgical repair of cartilage in a damaged or diseased joint, such as a knee, hip, or shoulder. In one method, the semi-permeable membrane is secured to the “articulating” surface (the exposed surface, as oppos...
01/13/2009
7282603Anhydrous processing of methane into methane-sulfonic acid, methanol, and other compounds
Anhydrous processing to convert methane into oxygenates (such as methanol), liquid fuels, or olefins uses an initiator to create methyl radicals. These radicals combine with sulfur trioxide to form methyl-sulfonate radicals. These radicals attack fresh methane, form...
10/16/2007
7243050Devices and systems for remote and automated monitoring and control of water removal, mold remediation, and similar work
Electronic devices, systems, and methods are disclosed for remote and/or automated monitoring of temperature, humidity, or other factors in a building during a remediation project, such as after a flood or mold infestation. These devices comprise sensors devices tha...
07/10/2007
7131613High-altitude launching of rockets lifted by helium devices and platforms with rotatable wings
A system is disclosed for lifting a rocket into the upper atmosphere and establishing forward flight at several hundred miles per hour, before the rocket engines are ignited and the rocket is released from the lifting system. The main subassemblies of this lifting s...
11/07/2006
6936279Microcrystalline zeaxanthin with high bioavailability in oily carrier formulations
Zeaxanthin (ZX) or other medically or commercially important carotenoids can be prepared in microcrystalline form, in an oily carrier liquid, to increase their bioavailability following oral ingestion. Initial processing is carried out to prepare a “rough” or ...
08/30/2005
6696071Pre-coital and post-coital rinse with anti-viral and skin-protective zinc salts
An aqueous douche or enema is disclosed, containing a water-soluble zinc salt at an anti-viral concentration, designed for use shortly before and/or shortly after intercourse. Unlike a lubricant for use during intercourse, this type of rinsing liquid will...
02/24/2004
6629997Meniscus-type implant with hydrogel surface reinforced by three-dimensional mesh
A device for surgical implantation to replace damaged tissue in a joint (such as a meniscus in a knee) is created from a hydrogel that is reinforced by a three-dimensional flexible fibrous mesh. In a meniscal implant, the mesh is exposed at one or more lo...
10/07/2003
6579293Intramedullary rod with interlocking oblique screw for tibio-calcaneal arthrodesis
A surgical rod-and-screw kit is disclosed, for use in ankle arthrodesis in patients who suffer from severe bone defects in their ankles. This assembly has a vertical intramedullary rod that is inserted through the bottom of the calcaneum (i.e., the heel b...
06/17/2003
6530956Resorbable scaffolds to promote cartilage regeneration
A load-sharing resorbable scaffold is used to help transplanted chondrocytes or other cells generate new cartilage in a damaged joint such as a knee, hip, or shoulder. These scaffolds use two distinct matrix materials. One is a relatively stiff matrix mat...
03/11/2003
6391871Preventing neuronal degeneration in Alzheimer's disease
A method of treating Alzheimer's disease is disclosed, not just with palliatives, but in a manner that prevents the progressive degeneration caused by Alzheimer's disease. Certain types of "safener" drugs, which can reduce the neurotoxic damage caused by ...
05/21/2002
6338866Pet foods using algal or fungal waste containing fatty acids
Methods are disclosed for using a waste product which remains when various types of algae (such as Crypthecodinium cohnii) or non-yeast fungi (such as Mortierella alpina) are used to manufacture essential fatty acids. This waste product is a biomass which...
01/15/2002
6207674Dextromethorphan and oxidase inhibitor for weaning patients from narcotics and anti-depressants
Patients can be helped to break free of addictive or habit-forming narcotics and anti-depressants, by treatment using two drugs. One drug is dextromethorphan (DM), which has been used for decades as an anti-tussive (cough-suppressing) drug in cough syrups...
03/27/2001
6194432Prevention and treatment of migraine, cluster and other recurrent headaches using leukotriene antagonist drugs
A method is disclosed for using leukotriene (LT) antagonist drugs to prevent and treat recurrent primary headaches, which includes migraine headaches and cluster headaches. LT antagonist drugs (such as montelukast and zafirlukast) are commercially availab...
02/27/2001
6132468Arthroscopic replacement of cartilage using flexible inflatable envelopes
A flexible "scaffold" envelope is disclosed which can be used to replace damaged cartilage in knees, shoulders, or other joints of a mammalian body. Designed for use in arthroscopic surgery, the envelope is sufficiently flexible to allow it to be rolled u...
10/17/2000
6076528Injection of fructose-1,6-diphosphate (FDP) prior to coronary artery bypass grafting surgery
Fructose-1,6-diphosphate (FDP) is used to treat patients who are undergoing coronary artery bypass grafting (CABG) surgery. Before cardiopulmonary bypass begins, a liquid that contains FDP is intravenously infused in the patient, preferably for about 10 t...
06/20/2000
6074658Treatment of sickle cell anemia crises with fructose-1, 6-diphosphate as an analgesic drug
Fructose-1,6-diphosphate (FDP) has been shown, in double-blinded controlled clinical trials on patients with sickle cell anemia, to substantially reduce the pain suffered by such patients during the recurrent ischemic crises that are caused by red blood c...
06/13/2000
6063819Neuroprotective poly-guanidino compounds which block presynaptic N and P/Q calcium channels
Neuroprotective drugs are disclosed with at least 3 branches extending outwardly from a center atom or group, each branch having a guanidino group at its terminus. All branches preferably should be identical, and distributed around the center atom or grou...
05/16/2000
6050737Securing system for transporting all-terrain vehicles
An all-terrain vehicle (ATV) can be secured to a truck or trailer bed, for transporting on roads or highways, using adjustable-length connectors with rigid shafts, rather than chains, ropes, or cables. Two steel "tine pins" (or comparable rigid structures...
04/18/2000
6011017Method of reducing pulmonary hypertension and atrial fibrillation after surgery using cardiopulmonary bypass
A method is disclosed for using fructose-1,6-diphosphate (FDP) to reduce and prevent two very serious problems caused by surgery that requires cardiopulmonary bypass. Before bypass begins, a liquid that contains FDP is intravenously injected into the pati...
01/04/2000
5980477Genital lubricants with zinc salts as anti-viral additives
This invention relates to the use of water-soluble zinc salts as anti-viral agents in genital lubricants (such as condom lubricants or stand-alone gels), to reduce the risk of infection by sexually transmitted viruses. Such zinc-containing anti-viral lubr...
11/09/1999
5958919Treatment of presymptomatic alzheimer's disease to prevent neuronal degeneration
Methods for treating the very early (presymptomatic) stages of Alzheimer's disease are disclosed, wherein NMDA antagonist drugs are administered to protect NMDA receptors against neuronal damage. Since NMDA antagonists may cause a condition known as NMDA ...
09/28/1999
5944020Use of fructose-1 6-diphosphate as an inotrope drug after cardiopulmonary bypass surgery
When fructose-1,6-diphosphate (FDP) is used as an inotropic drug in patients who have undergone surgery involving cardiopulmonary bypass, it can increase the pumping strength of a struggling heart, without increasing the heartbeat rate. As such, FDP can r...
08/31/1999
5934549Convertible folding box
A new type of folding box is disclosed, which is designed for redispatching to a second location, after it has been received at a first location. This box, which can be made from a single flat pre-cut blank, of cardboard or other suitable material, has tw...
08/10/1999
5925634Use of ibogaine for treating neuropathic pain
This invention discloses that ibogaine, a plant derivative, can be used safely to treat neuropathic pain (i.e, pain which does not respond conventionally to opiate drugs such as morphine). Ibogaine functions inside the CNS as an NMDA antagonist which is i...
07/20/1999
5910127On-site emergency treatment of injured or unconscious patients, using fructose-1,6-diphosphate (FDP)
A method and device are disclosed which enable on-site pre-diagnostic emergency treatment of people suffering from life-threatening injuries (such as victims of auto accidents, shootings, stabbings, and near-drownings), or from a collapse or loss of consc...
06/08/1999
5902815Use of 5HT-2A serotonin agonists to prevent adverse effects of NMDA receptor hypofunction
This invention relates to a new method for treating or preventing brain damage caused by NMDA receptor hypofunction (NR/hypo), using drugs such as lisuride which stimulate (agonize) activity at the 5HT-2A class of serotonin receptors, but which do not cau...
05/11/1999
5897066Claw drum for shredding used carpet
A rotating claw drum for shredding discarded material (such as used carpet) is created from flat circular plates that are stacked tightly together on a driveshaft or drum, to create an impermeable drum face that prevents particulates from entering and fou...
04/27/1999
5877173Preventing neuronal degeneration in Alzheimer's disease
A method for reducing progressive neuronal degeneration due to Alzheimer's disease is disclosed wherein a neuroprotective drug selected from the group consisting of clozapine, olanzapine and fluperlapine, and salts, isomers and analogs thereof, is adminis...
03/02/1999
5858985Treatment of asthma with fructose-1,6-diphosphate
Fructose-1,6-diphosphate (FDP), a sugar-phosphate compound, can be useful in treating asthma, when administered as an inhalable drug, either by itself or as a component of a mixed formulation. On a cellular level, inhalable FDP appears to offer at least f...
01/12/1999
5853210Pen and instrument holder for physically impaired hands
Devices are disclosed which can make writing and other tasks easier for people with physically impaired hands, such as people suffering from severe rheumatoid arthritis. These devices include a glove with a mounting attachment, for holding the base of a p...
12/29/1998
5854015Method of making pure 3R-3'R stereoisomer of zeaxanthin for human ingestion
A method is disclosed for making the 3R-3'R stereoisomer of zeaxanthin as a sole detectable or heavily dominant (more than about 90%) stereoisomer, for human ingestion. Zeaxanthin, a yellowish pigment which is naturally present in macular cells in the cen...
12/29/1998
5843643Site-specific transfection of eukaryotic cells using polypeptide-linked recombinant nucleic acid
A method and composition are disclosed for transfecting eukaryotic cells using a DNA segment coupled to a site-specific chromosome-binding polypeptide. The polypeptide-DNA conjugate is referred to herein as a polypeptide-linked-rDNA (PLR) molecule. One ex...
12/01/1998
5834465Treatment with combined NMDA and non-NMDA antagonists to reduce excitotoxic CNS damage
This invention involves a pharmaceutical mixture for preventing or reducing excitotoxic brain damage caused by hypoxia/ischemia (such as stroke) and various other factors. This mixture comprises an NMDA antagonist and a non-NMDA antagonist, both of which ...
11/10/1998
5827652Zeaxanthin formulations for human ingestion
Preparations are disclosed containing the 3R-3'R stereoisomer of zeaxanthin as a sole detectable isomer, packaged for oral ingestion by humans as a therapeutic drug or nutritional supplement. Zeaxanthin is a yellow carotenoid pigment found in the macula (...
10/27/1998
5785054Genital lubricant with zinc salt, labelled as anti-viral agent
This invention relates to an article of manufacture including a genital lubricant containing a selected non-irritating, water-soluble zinc salt at an anti-viral concentration, within a package that is provided with a label indicating that the lubricant is...
07/28/1998
5767130Use of kainic acid antagonists to prevent toxic side effects of NMDA antagonists
This invention discloses that kainic acid receptor antagonists (KA antagonists) can act as "safener" agents to reduce or prevent adverse side effects caused by NMDA antagonists. NMDA antagonists can reduce excitotoxic brain damage due to stroke, cardiac a...
06/16/1998
5747461Synergistic administration of cyclosporine and fructose diphosphate
This invention discloses a method of using fructose-1,6-diphosphate (FDP) to help suppress the rejection of internal organs such as kidneys, hearts, etc. At least three major advantages of FDP in conjunction with organ transplants have been identified: (1...
05/05/1998
5747544Method of using pure 3R-3'R stereoisomer of zeaxanthin to treat or prevent retinal degeneration in humans
A method is disclosed for treating or preventing macular degeneration, one of the leading causes of blindness and vision loss, by administering a preparation of zeaxanthin which contains the 3R-3'R stereoisomer as a sole or heavily dominant stereoisomer. ...
05/05/1998
1    
 
Sign InRegister
Username  
Password   
forgot password?